Fusetti, Chiara
Petri, Francesco http://orcid.org/0000-0003-0125-9551
Murad, Mohammad H.
Merli, Stefania
Giorgi, Riccardo
Rizzardini, Giuliano
Gori, Andrea
Passerini, Matteo
Funding for this research was provided by:
NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases
Università degli Studi di Milano
Article History
Received: 15 April 2024
Accepted: 23 May 2024
First Online: 11 June 2024
Declarations
:
: This is a systematic review of individual participant data. No ethics approval is required. The patient treated at our Institution and included in the review provided verbal informed consent to publication.
: CF, FP, SM, RG, MHM and MP declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. GR declare the following financial interests/personal relationships which may be considered as potential competing interests: honoraria for advisory committees, speaking and teaching from AbbVie, Angelini, Gilead, Janssen, GSK, Merck, ViiV, and gran and research support from AbbVie, Gilead, Merck, GSK. AG declare the following financial interests/personal relationships which may be considered as potential competing interests: honoraria from Janssen, ViiV, MSD, BMS, AbbVie, Gilead, Novartis, Pfizer, Astellas, Astrazeneca, Angelini.